Biography:
Dr. Razga has more than 20 years of professional experience in oncology with a focus on biotechnology within the last decade. He is trained in Physical and Biomolecular chemistry and has a primary research interest in RNA structure and function. He is currently leveraging his expertise in the development of new therapeutic modalities using the antisense platform to develop quality healthcare products that have the potential to redefine treatment outcomes. He is the author of more than 60 scientific papers and developed several proprietary technologies aiming at precise diagnosis and personalized therapeutic approaches.
Title : Effective reduction of SARS-CoV-2 RNA levels in transfected lung cells using a tailor-made therapeutic oligonucleotide